Table 4.
Time (days) | LPS | PCT-233 0·005% | PCT-233 0·05% | BUD | BUD + PCT-233 0·005% | BUD + PCT-233 0·05% |
---|---|---|---|---|---|---|
1 | 34·5 | 11·8 | 12·1 | 18·9 | 5·6 | 0·6 |
2 | 17·9 | 7·2 | 1·2 | 6·2 | 1·5 | 0·7 |
3 | 9·0 | 3·8 | 1·5 | 4·5 | 1·0 | 0·7 |
4 | 7·4 | 2·7 | 1·0 | 2·2 | 0·6 | 0·4 |
5 | 4·4 | 3·2 | 0·9 | 2·9 | 1·0 | 0·7 |
Alveolar macrophages were treated stimulated with LPS (10 ng/ml) for 18 h before being treated with PCT-233 and BUD (1 nm) alone or in combination and cell-free supernatants were collected at different times. The ratio was calculated by dividing TNF levels by IL-10 levels (ng/ml).